Macquarie Group LTD Otonomy, Inc. Transaction History

Macquarie Group LTD

  • $85.1 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$1.8 - $2.97 $5,940 - $9,801
-3,300 Closed
0 $0
Q4 2018

Feb 15, 2019
BUY
$1.51 - $2.93 $4,983 - $9,669
3,300 New
3,300 $6,000
Q1 2018

May 11, 2018
SELL
$4.05 - $6.1 $7,290 - $10,980
-1,800 Closed
0 $0
Q4 2017

Feb 15, 2018
BUY
$2.8 - $5.55 $5,040 - $9,990
1,800
1,800 $10,000

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email